Do you want to read an article? Please log in or register.
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines
Leukemia

van der Velden VHJ, Dombrink I, Alten J, Cazzaniga G, Clappier E, Drandi D, Eckert C, Fronkova E, Hancock J, Kotrova M, Kraemer R, Montonen M, Pfeifer H, Pott C, Raff T, Trautmann H, Cavé H, Schäfer BW, van Dongen JJM, Trka J, Brüggemann M, EuroMRD Consortium
Leukemia.
2024 May 14.
doi: 10.1038/s41375-024-02272-0.
Visit the full text of the original publication at nature.com